PRPO logo.png
Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers
October 23, 2018 09:15 ET | Precipio, Inc.
Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) --  Precipio, Inc. (NASDAQ: PRPO),...
PRPO logo.png
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
October 18, 2018 07:36 ET | Precipio, Inc.
Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology  NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the...
PRPO logo.png
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
September 20, 2018 07:37 ET | Precipio, Inc.
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
PRPO logo.png
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
June 06, 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...